[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 233 Introduced in Senate (IS)]
<DOC>
119th CONGRESS
1st Session
S. 233
To amend the Office of National Drug Control Policy Reauthorization Act
of 2006 to modify the authority of the Office of National Drug Control
Policy with respect to the World Anti-Doping Agency, and for other
purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
January 23, 2025
Mrs. Blackburn (for herself, Mr. Van Hollen, Mrs. Capito, Mr.
Blumenthal, and Mr. Wicker) introduced the following bill; which was
read twice and referred to the Committee on Commerce, Science, and
Transportation
_______________________________________________________________________
A BILL
To amend the Office of National Drug Control Policy Reauthorization Act
of 2006 to modify the authority of the Office of National Drug Control
Policy with respect to the World Anti-Doping Agency, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Restoring Confidence in the World
Anti-Doping Agency Act of 2025''.
SEC. 2. AUTHORITY OF NATIONAL DRUG CONTROL POLICY WITH RESPECT TO THE
WORLD ANTI-DOPING AGENCY.
Section 701 of the Office of National Drug Control Policy
Reauthorization Act of 2006 (21 U.S.C. 2001) is amended--
(1) in subsection (a)--
(A) by amending paragraph (1) to read as follows:
``(1) United states olympic and paralympic committee.--The
term `United States Olympic and Paralympic Committee' means the
organization established by chapter 2205 of title 36, United
States Code.'';
(B) in paragraph (3), by striking ``(36 U.S.C.
22501(b)(1))'' and inserting ``(36 U.S.C.
220501(b)(1))'';
(C) by redesignating paragraphs (1) and (3) as
paragraphs (4) and (1), respectively, and moving the
paragraphs so as to appear in numeric order; and
(D) by inserting after paragraph (2) the following:
``(3) Independent athlete.--The term `independent athlete'
means an Olympic or Paralympic athlete who does not serve, in
any capacity--
``(A) on the International Olympic Committee;
``(B) on the International Paralympic Committee;
``(C) at an international sports federation
recognized by the International Olympic Committee or
the International Paralympic Committee;
``(D) on the United States Olympic and Paralympic
Committee; or
``(E) at the World Anti-Doping Agency.'';
(2) in subsection (b)--
(A) by striking ``United States Olympic Committee''
each place it appears and inserting ``United States
Olympic and Paralympic Committee'';
(B) in paragraph (5), by striking the period at the
end and inserting ``; and''; and
(C) by adding at the end the following:
``(6) carry out responsibilities with respect to the World
Anti-Doping Agency, as described in subsection (d).''; and
(3) by adding at the end the following:
``(d) Authority With Respect to the World Anti-Doping Agency.--
``(1) In general.--The Office of National Drug Control
Policy, in consultation with the United States Anti-Doping
Agency, the United States Olympic and Paralympic Committee, and
the Team USA Athletes' Commission, shall--
``(A) use all available tools to ensure that--
``(i) the World Anti-Doping Agency has a
credible and independent governance model that
provides for fair representation of the United
States;
``(ii) the World Anti-Doping Agency fully
implements all governance reforms, including a
proper conflict-of-interest policy for all
members of the Executive Committee, the
Foundation Board, and all relevant expert
advisory groups, standing committees, permanent
special committees, and working groups of the
World Anti-Doping Agency; and
``(iii) independent athletes from the
United States and other democratic countries,
or representatives of such athletes, have
decision-making roles on the Executive
Committee and the Foundation Board, and in all
relevant expert advisory groups, standing
committees, permanent special committees, and
working groups, of the World Anti-Doping
Agency;
``(B) demonstrate leadership within the global
community;
``(C) have strict standards that work toward
countering doping in every form, including by
countering systemic fraud through doping involving--
``(i) governmental law enforcement,
intelligence, or anti-doping institutions;
``(ii) sporting organizations; or
``(iii) athlete support personnel; and
``(D) work collaboratively with democratic
countries.
``(2) Determination.--
``(A) In general.--Not later than 90 days after the
date of the enactment of this subsection, the Office of
National Drug Control Policy, in consultation with the
United States Anti-Doping Agency, the United States
Olympic and Paralympic Committee, and the Team USA
Athletes' Commission, shall make a determination as to
whether the World Anti-Doping Agency--
``(i) has a credible and independent
governance model that provides for fair
representation of the United States;
``(ii) fully implements all governance
reforms, including a proper conflict-of-
interest policy described in paragraph
(1)(A)(ii); and
``(iii) allows independent athletes from
the United States and other democratic
countries, or representatives of such athletes,
to have decision-making roles on the Executive
Committee and the Foundation Board, and in all
relevant expert advisory groups, standing
committees, permanent special committees, and
working groups, of the World Anti-Doping
Agency.
``(B) Accountability.--In the case of a
determination under subparagraph (A) that the World
Anti-Doping Agency does not have such a governance
model, has not fully implemented such governance
reforms, or has not allowed decision-making roles
described in clause (iii) of that subparagraph, the
Office of National Drug Control Policy, in consultation
with the United States Anti-Doping Agency, the United
States Olympic and Paralympic Committee, and the Team
USA Athletes' Commission, shall--
``(i) use all available tools to ensure
that the United States has fair representation
in the World Anti-Doping Agency, including--
``(I) on the Executive Committee;
``(II) on the Foundation Board; and
``(III) in all relevant expert
advisory groups, standing committees,
permanent special committees, and
working groups of the World Anti-Doping
Agency; and
``(ii) not later than 180 days after the
date on which the determination under
subparagraph (A) is made, issue a report that
describes the barriers to participation and
fair representation of the United States on the
Executive Committee, the Foundation Board, and
all relevant expert advisory groups, standing
committees, permanent special committees, and
working groups of the World Anti-Doping Agency.
``(3) Voluntary nonpayment of dues.--
``(A) In general.--In the case of a determination
under paragraph (2)(A) that the World Anti-Doping
Agency does not have a governance model that provides
for fair representation of the United States, has not
fully implemented governance reforms, or has not
allowed decision-making roles described in clause (iii)
of that subparagraph, the Office of National Drug
Control Policy, in consultation with the appropriate
committees of Congress, may voluntarily withhold up to
the full amount of membership dues to the World Anti-
Doping Agency.
``(B) Appropriate committees of congress defined.--
In this paragraph, the term `appropriate committees of
Congress' means--
``(i) the Subcommittee on Consumer
Protection, Product Safety, and Data Security
of the Committee on Commerce, Science, and
Transportation of the Senate (or a successor
subcommittee);
``(ii) the Subcommittee on Financial
Services and General Government of the
Committee on Appropriations of the Senate (or a
successor subcommittee);
``(iii) the Subcommittee on Oversight and
Investigations of the Committee on Energy and
Commerce of the House of Representatives (or a
successor subcommittee); and
``(iv) the Subcommittee on Financial
Services and General Government of the
Committee on Appropriations of the House of
Representatives (or a successor subcommittee).
``(4) Spending plan.--Not later than 30 days before the
Office of National Drug Control Policy obligates funds to the
World Anti-Doping Agency, the Office of National Drug Control
Policy shall submit to the Committee on Appropriations of the
Senate and the Committee on Appropriations of the House of
Representatives a spending plan and explanation of proposed
uses of such funds.''.
<all>